首页 / 院系成果 / 成果详情页

Propofol attenuates high glucose-induced P66shc expression in human umbilical vein endothelial cells through Sirt1  期刊论文  

  • 编号:
    ef00e854-3c0a-496d-bb3d-588f3dc43301
  • 作者:
  • 语种:
    英文
  • 期刊:
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA ISSN:1672-9145 2019 年 51 卷 2 期 (197 - 203) ; FEB
  • 收录:
  • 关键词:
  • 摘要:

    Perioperative hyperglycemia is a common metabolic disorder in clinic settings. Hyperglycemia leads to endothelial inflammation, endothelial cell apoptosis, and dysfunction, thus resulting in endothelial injury. Propofol (2,6-diisopropylphenol) is a widely used intravenous anesthetic in clinic settings. Our previous study indicated that propofol inhibits mitochondrial reactive oxygen species (ROS) production via down-regulation of phosphatase A2 (PP2A) expression, inhibition of Ser36-p66shc dephosphorylation and mitochondrial translocation, thus improving high glucose-induced endothelial injury. The expression of p66shc was inhibited by propofol in hyperglycemic human umbilical vein endothelial cells (HUVECs). However, the mechanism by which propofol inhibits p66shc expression in hyperglycemic HUVECs is still obscure. In the present study, we mainly examined how propofol inhibited high glucose-induced p66shc expression in HUVECs. Compared with 5 mM glucose treatment, high glucose increased p66shc expression and decreased sirt1 expression, which was inhibited by propofol treatment. Moreover, EX527 (a sirt1 inhibitor) reversed the effect of propofol against high glucose-induced p66shc expression. However, EX527 did not reverse the effects of propofol against high glucose-induced ROS accumulation, endothelial inflammation, and apoptosis. Furthermore, when cells were incubated with propofol, EX527, and FTY720 (a PP2A activator) simultaneously, the effects of propofol against high glucose-induced ROS accumulation, inflammation, and apoptosis were reversed. Our results suggested that propofol inhibited high glucose-induced p66shc expression via upregulation of sirt1 expression in hyperglycemic HUVECs. Moreover, propofol protects against high glucose-mediated ROS accumulation and endothelial injury via both inhibition of p66shc expression and dephosphorylation of Ser36-p66shc.

  • 推荐引用方式
    GB/T 7714:
    Wang Jing,Qi Jie,Wu Qichao, et al. Propofol attenuates high glucose-induced P66shc expression in human umbilical vein endothelial cells through Sirt1 [J].ACTA BIOCHIMICA ET BIOPHYSICA SINICA,2019,51(2):197-203.
  • APA:
    Wang Jing,Qi Jie,Wu Qichao,Jiang Hui,&Zhu Minmin.(2019).Propofol attenuates high glucose-induced P66shc expression in human umbilical vein endothelial cells through Sirt1 .ACTA BIOCHIMICA ET BIOPHYSICA SINICA,51(2):197-203.
  • MLA:
    Wang Jing, et al. "Propofol attenuates high glucose-induced P66shc expression in human umbilical vein endothelial cells through Sirt1" .ACTA BIOCHIMICA ET BIOPHYSICA SINICA 51,2(2019):197-203.
  • 条目包含文件:
    文件类型:PDF,文件大小:
    正在加载全文
浏览次数:6 下载次数:0
浏览次数:6
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部